US Stock MarketDetailed Quotes
ACUR Acura Pharmaceuticals Inc
- 0.020000
- 0.0000000.00%
15min DelayClose Jul 26 16:00 ET
1.32MMarket Cap-1000P/E (TTM)
0.000000High0.000000Low35Volume0.020000Open0.020000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)66.00MShares0.05000052wk High6.67P/B163.77KFloat Cap0.00000152wk Low--Dividend TTM8.19MShs Float1725.000000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
Acura Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -56.22%1.56M | -94.99%36K | -34.15%270K | -54.63%613K | -40.97%644K | 34.36%3.57M | -41.15%718K | -69.03%410K | 2,836.96%1.35M | 1,528.36%1.09M |
| Operating revenue | -56.22%1.56M | -94.99%36K | -34.15%270K | -54.63%613K | -40.97%644K | 34.36%3.57M | -41.15%718K | -69.03%410K | 2,836.96%1.35M | 1,528.36%1.09M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -35.84%2.78M | -67.84%273K | -17.85%801K | -1.83%913K | -49.81%790K | 27.97%4.33M | -10.73%849K | -3.75%975K | 39.22%930K | 109.87%1.57M |
| Selling and administrative expenses | -50.80%1.25M | -116.95%-71K | -8.77%416K | 7.84%523K | -67.57%385K | 35.70%2.55M | -13.79%419K | -16.79%456K | 19.46%485K | 171.62%1.19M |
| -General and administrative expense | -50.80%1.25M | -116.95%-71K | -8.77%416K | 7.84%523K | -67.57%385K | 35.70%2.55M | -13.79%419K | -16.79%456K | 19.46%485K | 171.62%1.19M |
| Research and development costs | -14.43%1.52M | -20.00%344K | -25.82%385K | -12.36%390K | 4.65%405K | 18.34%1.78M | -7.53%430K | 11.61%519K | 69.85%445K | 23.64%387K |
| Operating profit | -60.16%-1.21M | -80.92%-237K | 6.02%-531K | -171.26%-300K | 69.77%-146K | -4.55%-758K | -148.70%-131K | -281.67%-565K | 167.68%421K | 29.28%-483K |
| Net non-operating interest income expense | 55.56%-200K | 0 | 0 | 23.01%-87K | -0.89%-113K | -0.22%-450K | 1.75%-112K | -1.80%-113K | 5.04%-113K | -6.67%-112K |
| Non-operating interest expense | -55.56%200K | --0 | --0 | -23.01%87K | 0.89%113K | -2.60%450K | -1.75%112K | 1.80%113K | -8.13%113K | -1.75%112K |
| Other net income (expense) | 535K | 266K | 269K | |||||||
| Special income (charges) | --535K | --266K | --269K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Other special charges | ---535K | ---266K | ---269K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 27.24%-879K | 111.93%29K | 61.36%-262K | -225.65%-387K | 56.47%-259K | 67.99%-1.21M | -256.77%-243K | -439.00%-678K | 109.22%308K | 24.49%-595K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 27.24%-879K | 111.93%29K | 61.36%-262K | -225.65%-387K | 56.47%-259K | 67.99%-1.21M | -256.77%-243K | -439.00%-678K | 109.22%308K | 24.49%-595K |
| Net income continuous Operations | 27.24%-879K | 111.93%29K | 61.36%-262K | -225.65%-387K | 56.47%-259K | 67.99%-1.21M | -256.77%-243K | -439.00%-678K | 109.22%308K | 24.49%-595K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 27.24%-879K | 111.93%29K | 61.36%-262K | -225.65%-387K | 56.47%-259K | 67.99%-1.21M | -256.77%-243K | -439.00%-678K | 109.22%308K | 24.49%-595K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 27.24%-879K | 111.93%29K | 61.36%-262K | -225.65%-387K | 56.47%-259K | 67.99%-1.21M | -256.77%-243K | -439.00%-678K | 109.22%308K | 24.49%-595K |
| Basic earnings per share | 50.00%-0.02 | 103.84%0.0004 | 82.67%-0.0035 | -200.00%-0.01 | 50.00%-0.01 | 71.43%-0.04 | -304.88%-0.01 | -415.91%-0.02 | 106.67%0.01 | 50.00%-0.02 |
| Diluted earnings per share | 50.00%-0.02 | 103.84%0.0004 | 82.67%-0.0035 | -200.00%-0.01 | 50.00%-0.01 | 71.43%-0.04 | -304.88%-0.01 | -415.91%-0.02 | 106.67%0.01 | 50.00%-0.02 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg